Triatrial heart

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1463Q24.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Triatrial heart (cor triatriatum) is a rare congenital cardiac malformation in which the left atrium (cor triatriatum sinistrum) or, much less commonly, the right atrium (cor triatriatum dexter) is divided into two chambers by an abnormal fibromuscular membrane or septum. The most common form, cor triatriatum sinistrum, accounts for approximately 0.1–0.4% of all congenital heart defects. In this condition, the pulmonary veins drain into a proximal accessory chamber, which communicates with the true left atrium through one or more openings in the dividing membrane. The degree of obstruction to pulmonary venous return determines the severity of symptoms and the age at presentation. When the membrane is significantly obstructive, patients may present in infancy or early childhood with symptoms resembling mitral stenosis, including pulmonary venous congestion, pulmonary hypertension, dyspnea, recurrent respiratory infections, failure to thrive, and heart failure. In cases with a large or non-restrictive opening in the membrane, patients may remain asymptomatic into adulthood and the condition may be discovered incidentally. Associated cardiac anomalies, such as atrial septal defect, anomalous pulmonary venous return, patent ductus arteriosus, or left superior vena cava, are found in a significant proportion of cases and may influence the clinical presentation. Diagnosis is typically established through echocardiography, which can visualize the intra-atrial membrane and assess the degree of obstruction. Cardiac catheterization, CT, or MRI may be used for further anatomical delineation. The definitive treatment is surgical excision of the obstructing membrane, which carries excellent outcomes with low operative mortality when performed at experienced centers. Long-term prognosis after successful surgical repair is generally very good, with most patients achieving normal cardiac function. Asymptomatic patients with non-obstructive membranes may be managed conservatively with regular follow-up.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Triatrial heart.

View clinical trials →

No actively recruiting trials found for Triatrial heart at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Triatrial heart community →

No specialists are currently listed for Triatrial heart.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Triatrial heart.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Triatrial heartForum →

No community posts yet. Be the first to share your experience with Triatrial heart.

Start the conversation →

Latest news about Triatrial heart

No recent news articles for Triatrial heart.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Triatrial heart

What is Triatrial heart?

Triatrial heart (cor triatriatum) is a rare congenital cardiac malformation in which the left atrium (cor triatriatum sinistrum) or, much less commonly, the right atrium (cor triatriatum dexter) is divided into two chambers by an abnormal fibromuscular membrane or septum. The most common form, cor triatriatum sinistrum, accounts for approximately 0.1–0.4% of all congenital heart defects. In this condition, the pulmonary veins drain into a proximal accessory chamber, which communicates with the true left atrium through one or more openings in the dividing membrane. The degree of obstruction to

How is Triatrial heart inherited?

Triatrial heart follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.